Jim Simons Cor Medix Inc. Transaction History

Renaissance Technologies LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$4.08 - $6.39 $317,934 - $497,940	-77,925 Reduced 32.65%	160,734 $695,000
Q1 2024 May 13, 2024	BUY	$2.94 - $4.24 $8,699 - $12,546	2,959 Added 1.26%	238,659 $1.01 Million
Q4 2023 Feb 13, 2024	BUY	$3.0 - $4.01 $387,300 - $517,691	129,100 Added 121.11%	235,700 $886,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $383,760 - $475,436	106,600 New	106,600 $394,000
Q1 2023 May 12, 2023	BUY	$3.22 - $4.61 $348,159 - $498,451	108,124 Added 146.91%	181,724 $752,000
Q4 2022 Feb 13, 2023	BUY	$2.81 - $4.45 $168,600 - $267,000	60,000 Added 441.18%	73,600 $311,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $38,352 - $102,272	13,600 New	13,600 $38,000
Q2 2022 Aug 12, 2022	SELL	$2.73 - $5.61 $27,728 - $56,980	-10,157 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.83 - $6.24 $38,901 - $63,379	10,157 New	10,157 $56,000
Q4 2021 Feb 11, 2022	SELL	$4.47 - $5.56 $527,464 - $656,085	-118,001 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.46 - $7.11 $526,284 - $838,987	118,001 New	118,001 $549,000
Q1 2021 May 13, 2021	SELL	$6.84 - $17.58 $298,908 - $768,245	-43,700 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$5.0 - $9.15 $218,500 - $399,855	43,700 New	43,700 $325,000
Q2 2020 Aug 13, 2020	SELL	$3.08 - $6.56 $397,012 - $845,584	-128,900 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.35 - $7.08 $170,375 - $513,300	72,500 Added 128.55%	128,900 $463,000
Q4 2019 Feb 13, 2020	BUY	$4.96 - $7.75 $279,744 - $437,100	56,400 New	56,400 $411,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.